↓ Skip to main content

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

Overview of attention for article published in Journal of Clinical Oncology, March 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

news
1 news outlet
twitter
20 X users
patent
3 patents
facebook
1 Facebook page
guideline
3 clinical guideline sources

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 <1%
Unknown 105 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 18 17%
Other 12 11%
Student > Postgraduate 7 7%
Professor 6 6%
Student > Ph. D. Student 5 5%
Other 18 17%
Unknown 40 38%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 37 35%
Biochemistry, Genetics and Molecular Biology 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Nursing and Health Professions 3 3%
Business, Management and Accounting 2 2%
Other 7 7%
Unknown 47 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 October 2025.
All research outputs
#1,578,094
of 34,583,980 outputs
Outputs from Journal of Clinical Oncology
#4,438
of 32,781 outputs
Outputs of similar age
#23,223
of 352,914 outputs
Outputs of similar age from Journal of Clinical Oncology
#101
of 263 outputs
Altmetric has tracked 34,583,980 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,781 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,914 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 263 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.